Necmettin AKDENİZ, Hasan Hüseyin MUTLU, Ayşe Serap KARADAĞ, Emin ÖZLÜ, Mümtaz TAKIR, Zafer TÜRKOĞLU, Osman KÖSTEK, Tuğba Kevser UZUNÇAKMAK

Skin findings in autoimmune and nonautoimmune thyroid disease with respect to thyroid functional status and healthy controls

Background/aim: Thyroid disorders are associated with a wide variety of skin disorders that respond to treatment of hormone imbalance in most cases and thus are of vital importance to dermatologists. This study aimed to evaluate skin findings associated with autoimmune and nonautoimmune thyroid disease with respect to thyroid functional status and healthy controls. Materials and methods: A total of 300 consecutive patients with either autoimmune (n = 173) or nonautoimmune (n = 127) thyroid disease and 100 healthy control subjects were included in this cross-sectional study. Data on patient demographics, thyroid function tests, and skin findings were recorded for patient and control groups. Results: Compared to control subjects, patients had higher proportions in populations with alopecia (P < 0.001), nail thinning (P = 0.02), brittle nails (P = 0.001), pruritus (P < 0.001), diffuse hyperhidrosis (P = 0.01), flushing (P = 0.001), and xerosis (P < 0.001). Onycholysis (P = 0.02), yellow skin (P = 0.04), periorbital edema (P = 0.03), psoriasis (P = 0.001), and palmoplantar hyperkeratosis (P = 0.007) were significantly more common in patients with autoimmune than nonautoimmune thyroid disease. A significantly higher percentage of patients with autoimmune rather than nonautoimmune thyroid disease had overall skin findings (P = 0.03) among the hyperthyroid patients. Conclusions: Our findings indicate that the presence of skin findings in a majority of thyroid patients significantly differs for certain cutaneous manifestations with respect to controls, autoimmune etiology, and thyroid functional status.

PDF

___

1. Heymann WR. Advances in the cutaneous manifestations of thyroid disease. Int J Dermatol 1997; 36: 641-645.
2. Doshi DN, Blyumin ML, Kimball AB. Cutaneous manifestations of thyroid disease. Clin Dermatol 2008; 26: 283-287.
3. Mullin GE, Eastern JS. Cutaneous signs of thyroid disease. Am Fam Physician 1986; 34: 93-98.
4. Weetman AP. Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum. Clin Endocrinol (Oxf) 2011; 74: 411-418.
5. Ai J, Leonhardt JM, Heymann WR. Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations. J Am Acad Dermatol 2003; 48: 641-659.
6. Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev 2015; 14: 174-180.
7. Artantaş S, Gül U, Kiliç A, Güler S. Skin findings in thyroid diseases. Eur J Intern Med 2009; 20: 158-161.
8. Burman KD, McKinley-Grant L. Dermatological aspects of thyroid disease. Clin Dermatol 2006; 24: 247-255.
9. Niepomnisczhe H, Amad RH. Skin disorders and thyroid diseases. J Endocrinol Invest 2001; 24: 628-638.
10. Jabbour SA. Cutaneous manifestations of endocrine disorders. A guide for dermatologists. Am J Clin Dermatol 2003; 4: 315- 331.
11. Jabbour SA, Miller JL. Endocrinopathies and the skin. Int J Dermatol 2000; 39: 88-99.
12. Heymann WR, Gans EH, Manders SM, Green JJ, Haimowitz JE. Xerosis in hypothyroidism: a potential role for the use of topical thyroid hormone in euthyroid patients. Med Hypotheses 2001; 57: 736-739.
13. Roberts CG, Ladenson PW. Hypothyroidism. Lancet 2004; 363: 793-803.
14. Zauli D, Grassi A, Ballardini G, Contestabile S, Zucchini S, Bianchi FB. Thyroid autoimmunity in chronic idiopathic urticaria: implications for therapy. Am J Clin Dermatol 2002; 3: 525-528.
15. Tan E, Tay YK, Goh CL, Giam YC. The pattern and profile of alopecia areata in Singapore-a study of 219 Asians. Int J Dermatol 2002; 41: 748-753.
16. Barahmani N, Schabath MB, Duvic M; National Alopecia Areata Registry. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 2009; 61: 581-591.
17. Leonhardt JM, Heymann WR. Thyroid disease and the skin. Dermatol Clin 2002; 20: 473-481.
18. Bahn RS. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves ophthalmopathy. J Endocrinol Invest 2004; 27: 216-220.
19. Fatourechi V, Ahmed DD, Schwartz KM. Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab 2002; 87: 5435-5441.
20. Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab 2003; 88: 2100-2105.
21. Bartley GB. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. T Am Ophthal Soc 1994; 92: 477-588.
22. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H, Taube A. Occurrence of ophthalmopathy after treatment for Graves hyperthyroidism. The Thyroid Study Group. N Engl J Med 1992; 326: 1733-1738.
23. Rottem M. Chronic urticaria and autoimmune thyroid disease: is there a link? Autoimmun Rev 2003; 2: 69-72.